Tanguy Laportaliere-De
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Optimizing antidepressant use in geriatric depression: expert consensus from French societies of geriatrics, old age psychiatry, and clinical pharmacy (SFGG, SF3PA, and SFPC).
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: March 26, 2026
Hyperprolactinemia following a single dose of risperidone: A case report.
Journal: Therapie
Published: October 20, 2025
Safety of Intranasal Esketamine Administration in Brugada Syndrome: Two Clinical Case Reports.
Journal: Journal of clinical psychopharmacology
Published: September 23, 2025
Response to "Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out".
Journal: Drug and alcohol review
Published: April 04, 2025
Association between major cardiovascular events and esketamine: A disproportionality analysis in the WHO pharmacovigilance database.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: February 26, 2025
First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.
Journal: Drug and alcohol review
Published: June 17, 2024
Drug-induced psychiatric disorders: A pharmacovigilance update.
Journal: Therapie
Published: August 14, 2023
Reporting of harms in clinical trials of esketamine in depression: a systematic review.
Journal: Psychological medicine
Published: May 15, 2023
Funding of psychiatry in France, the problem of expensive drugs. Example of Esketamine in the case of resistant depressive episodes
Journal: L'Encephale
Published: February 01, 2023
How to deprescribe esketamine in resistant depression? A point of view after first clinical uses.
Journal: Epidemiology and psychiatric sciences
Published: January 11, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026